Article: Thomas, McNerney & Partners, LLC, Raises $216 Million for its Inaugural Health Care Private Equity Fund; Fund to Focus on Investment Opportunities of All Stages in the Pharmaceutical, Medical Device and Biotechnology Sectors.

NEW YORK, MINNEAPOLIS and SAN FRANCISCO -- NEW YORK, MINNEAPOLIS and SAN FRANCISCO, May 6 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a newly-formed health care private equity firm that invests in life science and medical technology companies, announced it has closed its initial fund, Thomas, McNerney & Partners, L.P. (formerly Lumina Ventures, L.P.). Committed capital totaled $216 million and was raised from a broad mix of institutional investors, including pension funds, university endowments, foundations and insurance companies. Thomas, McNerney & Partners has a broad mandate to invest in companies at all stages of development in the medical device, ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!